Overexpression of plasminogen activator inhibitor (PAI‐1), an inhibitor of t‐PA and urokinase plasminogen activator (u‐PA), in an AAA rat model prevented aneurysm formation by the inhibition of plasminogen activators and MMP.111. The gene discussed is PLAU; the disease is triple-A syndrome.